Data as of Apr 9, 2026 · A question buyers ask in Deep Tech Venture Capital Firms. · See how Parse measures this
Between March and April 2026, AI assistants split their top recommendations for patient deep tech capital between and , with both capturing an equal share of mentions. trailed closely as the third most-cited firm, reflecting a competitive landscape where no single fund dominates AI answers for this need.
DCVCWhere a different pick wins:
EIC Accelerators offers a hybrid grant-equity model up to 17.5M euros, designed for long R&D timelines in Europe.
SBIR provides non-dilutive grants for early-stage deep tech, often serving as 'America's Seed Fund'.
Third Rock partners with scientific founders and supports extended clinical development, making it a go-to for biotech.
SOSVSOSV's IndieBio and HAX accelerators provide lab space and intensive support for hardware and life sciences startups.
Khosla VenturesKhosla Ventures is frequently recommended for high-risk sustainability and clean energy bets that demand patient capital.
Cited as a deep tech VC investing in hard science and computational problems with a long-term thesis.
Structured to support 'tough tech' startups with patient capital and lab facilities.
We ask this question several ways, so the answer is about what buyers want and not about how it happens to be asked.
Data as of Apr 9, 2026 · A question buyers ask in Deep Tech Venture Capital Firms. · See how Parse measures this
DCVC
The EngineBetween March and April 2026, AI assistants split their top recommendations for patient deep tech capital between
Khosla VenturesAI answered this with a wide list of deep tech VCs, but
Where a different pick wins:
EIC Accelerators offers a hybrid grant-equity model up to 17.5M euros, designed for long R&D timelines in Europe.
SBIR provides non-dilutive grants for early-stage deep tech, often serving as 'America's Seed Fund'.
Third Rock partners with scientific founders and supports extended clinical development, making it a go-to for biotech.
SOSVSOSV's IndieBio and HAX accelerators provide lab space and intensive support for hardware and life sciences startups.
Khosla VenturesKhosla Ventures is frequently recommended for high-risk sustainability and clean energy bets that demand patient capital.
Cited as a deep tech VC investing in hard science and computational problems with a long-term thesis.
Structured to support 'tough tech' startups with patient capital and lab facilities.
We ask this question several ways, so the answer is about what buyers want and not about how it happens to be asked.
DCVCThe EngineKhosla VenturesAI answered this with a wide list of deep tech VCs, but
